Carboxypeptidase U

Handbook of Proteolytic Enzymes, Second Edition: Volume 1: Aspartic and Metallo Peptidases

Volumn 1, Issue , 2004, Pages 825-828

  Hendriks, Dirk F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20444425005     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-079611-3.50250-0     Document Type: Chapter

References (39)

1. L. Bajzar, R. Manuel and M. Nesheim (1995) Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J. Biol. Chem. 270 14477-14484.
2. L. Bajzar, J. Morser and M. Nesheim (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271 16603-16608.
3. M.B. Boffa, W. Wang, L. Bajzar and M.E. Nesheim (1998) Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J. Biol. Chem. 273 2127-2135.
4. M.B. Boffa, T.S. Reid, E. Joo, M.E. Nesheim and M.L. Koschinsky (1999) Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry 38 6547-6558.
5. G.J. Broze Jr. (1996) Thrombin-dependent inhibition of fibrinolysis. Curr. Opin. Hematol. 3 390-394.
6. W. Campbell and H. Okada (1989) An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162 933-939.
7. W. Campbell, K. Yonezu, T. Shinohara and H. Okada (1990) An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J. Lab. Clin. Med. 115 610-612.
8. W. Campbell, E. Lazoura, N. Okada and H. Okada (2002) Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46 131-134.
9. D.L. Eaton, B.E. Malloy, S.P. Tsai, W. Henzel and D. Drayna (1991) Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266 21833-21838.
10. X. Guo, A. Morioka, Y. Kaneko, N. Okada, K. Obata, T. Nomura, W. Campbell and H. Okada (1999) Arginine carboxypeptidase (CPR) in human plasma determined with sandwich ELISA. Microbiol. Immunol. 43 691-698.
11. D. Hendriks, S. Scharpé and M. van Sande (1985) Assay of carboxypeptidase N is serum by liquid chromatographic determination of hippuric acid. Clin. Chem. 31 1936-1939.
12. D. Hendriks, S. Scharpé and M. van Sande (1988) Partial purification and characterization of a new arginine carboxypeptidase from human serum. J. Clin. Chem. Clin. Biochem. 26 305.
13. D. Hendriks, S. Scharpé, M. van Sande and M.P. Lommaert (1989) A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N. Clin. Chem. 35 177.
14. D. Hendriks, S. Scharpé, M. van Sande and M.P. Lommaert (1989) Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J. Clin. Chem. Clin. Biochem. 27 277-285.
15. D. Hendriks, W. Wang, S. Scharpé, M.P. Lommaert and M. van Sande (1990) Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim. Biophys. Acta 1034 86-92.
16. D. Hendriks, W. Wang, M. van Sande and S. Scharpé (1992) Human serum carboxypeptidase U: a new kininase? Agents Actions 38/I 407-413.
17. T. Kato, H. Akatsu, T. Sato, S. Matsuo, T. Yamamoto, W. Campbell, N. Hotta, N. Okada and H. Okada (2000) Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 44 719-728.
18. P. Klement, P. Liao and L. Bajzar (1999) A novel approach to arterial thrombolysis. Blood 94 2735-2743.
19. P.F. Marx, T.M. Hackeng, P.E. Dawson, J.H. Griffin, J.C. Meijers and B.N. Bouma (2000) Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. J. Biol. Chem. 275 12410-12415.
20. P.F. Marx, G.T. Wagenaar, A. Reijerkerk, M.J. Tiekstra, A.G. van Rossum, M.F. Gebbink and J.C. Meijers (2000) Characterization of mouse thrombin-activatable fibrinolysis inhibitor. Thromb. Haemost. 83 297-303.
21. C. Mattson, J.-A. Bjorkman, T. Abrahamsson, V. Nerme, S. Scharpé and D. Hendriks (2000) Melagatran, the active form of the oral, direct thrombin inhibitor H 376/95, enhances the thrombolytic effects of tissue type plasminogen activator: a possible mechanism being inhibition of thrombin-mediated pro-CPU activation. Blood 96 52a.
22. M.C. Minnema, P.W. Friederich, M. Levi, P.A. von dem Borne, L.O. Mosnier, J.C. Meijers, B.J. Biemond, C.E. Hack, B.N. Bouma and H. Ten Cate (1998) Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J. Clin. Invest. 101 10-14.
23. L.O. Mosnier, P.A. von dem Borne, J.C. Meijers and B.N. Bouma (1998) Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb. Haemost. 80 829-835.
24. M. Nagashima, M. Werner, M. Wang, L. Zhao, D.R. Light, R. Pagila, J. Morser and P. Verhallen (2000) An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis Model. Thromb. Res. 98 333-342.
25. A. Redlitz, A.K. Tan, D.L. Eaton and E.F. Plow (1995) Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96 2534-2538.
26. A. Redlitz, F.A. Nicolini, J.L. Malycky, E.J. Topol and E.F. Plow (1996) Inducible carboxypeptidase activity: a role in clot lysis in vivo. Circulation 93 1328-1330.
27. C.J. Refino, L. Deguzman, D. Schmitt, R. Smyth, S. Jeet, M.T. Lipari, D.L. Eaton and S. Bunting (2000) Consequences of inhibition of plasma carboxypeptidase B on in vivo thrombolysis, thrombosis and hemostasis. Fibrinol. Proteol. 14 305-314.
28. K.A. Schatteman, F.J. Goossens, S.S. Scharpé, H.M. Neels and D.F. Hendriks (1999) Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin. Chem. 45 807-813.
29. K.A. Schatteman, F.J. Goossens, S.S. Scharpé and D.F. Hendriks (1999) Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis. Thromb. Haemost. 82 1718-1721.
30. K.A. Schatteman, F. Goossens, J. Leurs, Y. Kasahara, S.S. Scharpé and D. Hendriks (2001) Fast homogeneous assay for plasma procarboxypeptidase U. Clin. Chem. Lab. Med. 39 806-810.
31. T. Shinohara, C. Sakurada, T. Suzuki, W. Campbell, S. Ikeda, N. Okada and H. Okada (1994) Pro-carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103 400-404.
32. R.A. Skidgel (1988) Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol. Sci. 9 299-304.
33. M. Stromqvist, K. Schatteman, J. Leurs, R. Verkerk, J.O. Andersson, T. Johansson, S. Scharpé and D. Hendriks (2001) Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma. Thromb. Haemost. 85 12-17.
34. A.K. Tan and D.L. Eaton (1995) Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry 34 5811-5816.
35. S.P. Tsai and D. Drayna (1992) The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13. Genomics 14 549-550.
36. Z. Valnickova and J.J. Enghild (1998) Human procarboxypeptidase U, or thrombin activatable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase catalyzed cross-linking to fibrin. J. Biol. Chem. 273 27220-27224.
37. G. Vanhoof, J. Wauters, K. Schatteman, D. Hendriks, F. Goossens, P. Bossyt and S. Scharpé (1996) The gene for human carboxypeptidase U (CPU) – a proposed novel regulator of plasminogen activation – maps to 13q14.11. Genomics 38 454-455.
38. W. Wang, D. Hendriks and S. Scharpé (1994) Carboxypeptidase U: a new plasma carboxypeptidase with high affinity for plasminogen. J. Biol. Chem. 269 15937-15944.
39. W. Wang, M.B. Boffa, L. Bajzar, J.B. Walker and M.E. Nesheim (1998) A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 273 27176-27181.